Tysabri news is good for ISEQ
The ISEQ index climbed 121.78 points to 7894.62 this morning.
Elan soared €2.40 (21.2%) to €13.70 following news that multiple sclerosis drug Tysabri is expected to be approved to go back on sale shortly. It was the morning’s busiest share.